Motor neurone disease
There is no cure for ALS. However, the Food and Drug Administration (FDA) has approved the first drug treatment for the disease: riluzole. Riluzole is believed to reduce damage to motor neurons. Clinical trials with ALS patients showed that riluzole gives a better chance of survival by several months, mainly in those with a hard time swallowing. The drug also allows more time before a patient needs breathing help by a ventilator or tracheotomy. Riluzole does not heal the damage already done to motor neurons.